US STOCK
GMED Stock Analysis
US stocks · market data · technical indicators
GLOBUS MEDICAL INC
GMEDUS stocksQuote delayed 15 min
10/26 下午04:33 updated
$81.41
-0.25-0.31%
Open
$81.06
High
$82.01
Low
$80.40
Volume
76.85萬
GMED price history
+8.87%Open
74.78
Latest
81.41
High
81.66
Low
73.33
Average
76.54
Advertisement
Financial snapshot
GMED - Globus Medical, Inc.
EPS
3.90USD
Forward EPS
5.39USD
P/E
20.87x
Forward P/E
15.10x
P/B
2.29x
ROE
11.81%
ROA
8.74%
Operating margin
24.76%
Profit margin
17.03%
Revenue growth
5.90%
Earnings growth
-26.20%
Dividend yield
0.00%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $789.61M | $759.85M | $826.42M | $769.05M | $745.34M |
| Gross profit | $548.17M | $525.79M | $565.31M | $516.51M | $496.58M |
| Operating income | $195.47M | $161.98M | $181.31M | $135.01M | $122.81M |
| Net income | $151.57M | $124.30M | $140.59M | $118.97M | $202.85M |
| Basic EPS | 1.12 | 0.92 | 1.05 | 0.88 | 1.50 |
| Diluted EPS | 1.10 | 0.90 | 1.03 | 0.88 | 1.49 |
Estimates vs actuals
Next earnings
2026-11-05
EPS estimate
1.20
Revenue estimate
$792.46M
Last surprise
+21.91%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-11-05 | 1.20 | Not reported | — |
| 2026-08-06 | 1.10 | 1.34 | +21.91% |
| 2026-05-07 | 0.92 | 1.12 | +21.73% |
| 2026-02-24 | 1.15 | 1.28 | +10.96% |
| 2025-11-06 | 0.78 | 1.18 | +51.14% |
| 2025-08-07 | 0.75 | 0.86 | +14.92% |
| 2025-05-08 | 0.75 | 0.68 | -9.16% |
| 2025-02-20 | 0.75 | 0.84 | +12.21% |
| 2024-11-05 | 0.65 | 0.83 | +28.28% |
| 2024-08-06 | 0.68 | 0.75 | +10.73% |
| 2024-05-07 | 0.57 | 0.72 | +26.98% |
| 2024-02-20 | 0.61 | 0.60 | -1.67% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $921.1M | 0.01% |
| BlackRock Inc. | 2024-06-30 | $708.2M | 0.02% |
| STATE STREET CORP | 2026-06-30 | $293.5M | 0.01% |
| Bridgewater Associates, LP | 2026-06-30 | $27.8M | 0.11% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $15.6M | 0.02% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$100.92
Target range
$84.00 – $125.00
Implied upside
23.97%
Strong buy
3
Buy
7
Hold
4
Sell
0
Strong sell
0
Advertisement